CERO THERAPEUTICS HOLDINGS, INC.

CERO Therapeutics Holdings, Inc.

Biotechnology Healthcare South San Francisco, CA, United States CEROW (NGM)

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.

Stock Performance (90 Days)

Data through Dec 23, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Biotechnology Companies

View All →

Frequently Asked Questions

Has CERO THERAPEUTICS HOLDINGS, INC. had layoffs?
No layoff events have been recorded for CERO THERAPEUTICS HOLDINGS, INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does CERO THERAPEUTICS HOLDINGS, INC. have?
CERO THERAPEUTICS HOLDINGS, INC. has approximately 8 employees.
What industry is CERO THERAPEUTICS HOLDINGS, INC. in?
CERO THERAPEUTICS HOLDINGS, INC. operates in the Biotechnology industry, within the Healthcare sector.
Is CERO THERAPEUTICS HOLDINGS, INC. a publicly traded company?
Yes, CERO THERAPEUTICS HOLDINGS, INC. is publicly traded under the ticker symbol CEROW on the NGM.
Where is CERO THERAPEUTICS HOLDINGS, INC. headquartered?
CERO THERAPEUTICS HOLDINGS, INC. is headquartered in South San Francisco, CA, United States at 201 Haskins Way, South San Francisco, CA 94080, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.